Ozlam (Apremilast)

Apremilast, the active ingredient in Ozlam, is a phosphodiesterase‑4 (PDE4) inhibitor presented as an oral tablet for systemic use. It is indicated for the treatment of certain chronic inflammatory skin conditions in adult patients. GNH USA supplies Ozlam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Ozlam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Apremilast is a phosphodiesterase‑4 inhibitor used in dermatology and rheumatology to modify inflammatory pathways.

- Plaque psoriasis: reduces skin lesions and improves quality of life. - Psoriatic arthritis: alleviates joint pain and swelling. - Behçet's disease oral ulcers: promotes healing of recurrent mouth ulcers.

Apremilast may exhibit several     …  … …  ...  … … … …  …